BpV (phen) induces apoptosis of RINm5F cells by modulation of MAPKs and MKP-1

Biochemical and Biophysical Research Communications

Volumn 300, Issue 4, 2003, Pages 877-883

  Rumora, Lada ^a   Barišić, Karmela ^a   Maysinger, Dusica ^b   Žanić Grubišić, Tihana ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Apoptosis; MAPK; MKP 1; Peroxovanadium; RINm5F cells

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PEROXOVANADIUM; SYNAPTOPHYSIN; TACROLIMUS; UNCLASSIFIED DRUG; VANADIUM DERIVATIVE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT;

EID: 0037462885     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02952-2     Document Type: Article

References (30)

1. Sekar N., Li J., Shechter Y. Vanadium salts as insulin substitutes: mechanisms of action, a scientific and therapeutic tool in diabetes mellitus research. Crit. Rev. Biochem. Mol. Biol. 31:1996;339-359.
2. Llobet J.M., Domingo J.L. Acute toxicity of vanadium compounds in rats and mice. Toxicol. Lett. 23:1984;227-231.
3. Domingo J.L., Gomez M., Sanchez D.J., Llobet J.M., Keen C.L. Toxicology of vanadium compounds in diabetic rats: the action of chelating agents on vanadium accumulation. Mol. Cell. Biochem. 153:1995;233-240.
4. Fawcett J.P., Farquhar S.J., Thout T., Shand B.I. Oral vanadyl sulphate does not affect blood cells, viscosity or biochemistry. Pharmacol. Toxicol. 80:1997;206-222.
5. Poucheret P., Verma S., Grynpas M.D., McNeil J.H. Vanadium and diabetes. Mol. Cell. Biochem. 188:1998;73-80.
6. Reul B.A., Amin S.S., Buchet J.P., Ongemba L.N., Crans D.C., Brichard S.M. Effect of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats. Br. J. Pharmacol. 126:1999;467-477.
7. Younes M., Strubelt O. Vanadate-induced toxicity towards isolated perfused rat livers: the role of lipid peroxidation. Toxicology. 66:1991;63-74.
8. Younes M., Kayser E., Strubelt O. Effect of antioxidants on vanadate-induced toxicity towards isolated perfused rat livers. Toxicology. 70:1991;141-149.
9. Domingo J.L. Vanadium and diabetes. What about vanadium toxicity? Mol. Cell. Biochem. 203:2000;185-187.
10. Pepato M.T., Magnani M.R., Kettelhut I.C., Brunetti I.L. Effect of oral vanadyl sulphate treatment on serum enzymes and lipids of streptozotocin-diabetic young rats. Mol. Cell. Biochem. 198:1999;157-161.
11. Brichard S.M., Henquin J.C. The role of vanadium in the management of diabetes. Trends Pharmacol. Sci. 16:1995;265-270.
12. Posner B.I., Faure R., Burgess J.W., Bevan A.P., Lachance D., Zhang-Sun D., Fantus I.G., Ng J.B., Hall D.A., Soo Lum B., Shaver A. Peroxovanadium compounds. J. Biol. Chem. 269:1994;4596-4604.
13. Cruz T.F., Morgan A., Min W. In vitro and in vivo antineoplastic effects of ortovanadate. Mol. Cell. Biochem. 153:1995;161-166.
14. Chen Y.R., Tan T.H. The c-Jun N-terminal kinase pathway and apoptotic signaling. Int. J. Oncol. 16:2000;651-662.
15. Schaeffer H.J., Weber M.J. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19:1999;2435-2444.
16. Mustelin T., Brockdorff J., Gjörloff-Wingren A., Tailor P., Han S., Wang X., Saxena M. Lymphocyte activation: the coming of the protein tyrosine phosphatases. Front. Biosci. 3:1998;1060-1096.
17. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
18. Hatai T., Matsuzawa A., Inoshita S., Mochida Y., Kuroda T., Sakamaki K., Kuida K., Yonehara S., Ichijo H., Takeda K. Execution of apoptosis signal-regulating kinase 1 (ASK1)-induced apoptosis by the mitochondria-dependent caspase activation. J. Biol. Chem. 275:2000;26576-26581.
19. Rumora L., Shaver A., Žanić Grubišić T., Maysinger D. MKP-1 as a target for pharmacological manipulations in PC12 cell survival. Neurochem. Int. 39:2001;25-32.
20. Gazdar A.F., Chick W.L., Oie H.K., Sims H.L., King D.L., Weir G.C., Lauris V. Continuous, clonal, insulin- somatostatin-secreting cell lines established from a transplantable rat islet cell tumor. Proc. Natl. Acad. Sci. USA. 77:1980;3519-3523.
21. Cerovac Z., Ban J., Morinville A., Yaccato K., Shaver A., Maysinger D. Activation of MAPK by potassium bisperoxo(1,10-phenanthroline)oxovanadate (V). Neurochem. Int. 34:1999;337-344.
22. Daum G., Kalmes A., Levkau B., Wang Y., Davies M.G., Clowes A.W. Pervanadate inhibits mitogen-activated protein kinase kinase-1 in a p38MAPK-dependent manner. FEBS Lett. 427:1998;271-274.
23. Natarajan V., Scribner W.M., Morris A.J., Roy S., Vepa S., Yang J., Wadgaonkar R., Reddy S.P., Garcia J.G., Parinandi N.L. Role of p38 MAP kinase in diperoxovanadate-induced phospholipase D activation in endothelial cells. Am. J. Physiol. Lung Cell. Moll. Physiol. 281:2001;L435-L449.
24. Morinville A., Maysinger D., Shaver A. From Vanadis to Atropos: vanadium compounds as pharmacological tools in cell death signaling. Trends Pharmacol. Sci. 19:1998;452-460.
25. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell. 103:2000;239-252.
26. Rumora L., Shaver A., Žanić-Grubišić T., Maysinger D. Differential regulation of JNK activation and MKP-1 expression by peroxovanadium complexes. Neurochem. Int. 38:2001;341-347.
27. Winter Ch., Schenkel J., Zimmermann M., Herdegen T. MAP kinase phosphatase 1 is expressed and enhanced by FK506 in surviving mamillary, but not nigral neurons following axotomy. Brain Res. 801:1998;198-205.
28. Franklin C.C., Kraft A.S. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J. Biol. Chem. 272:1997;16917-16923.
29. Grumont R.J., Rasko J.E., Strasser A., Gerondakis S. Activation of the mitogen-activated protein kinase pathway induces transcription of the PAC-1 phosphatase gene. Mol. Cell. Biol. 16:1996;2913-2921.
30. Tournier C., Hess P., Yang D.D., Xu J., Turner T.K., Nimnual A., Bar-Sagi D., Jones S.N., Flavell R.A., Davis R.J. Requirement of JNK for stress-induced activation of the cytocrome c-mediated death pathway. Science. 288:2000;870-874.